NCT03994315View on ClinicalTrials.gov

The EFFECT Study: Probiotic and HMO Supplementation in Infants

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

September 12, 2019

Primary Completion Date

March 13, 2020

Study Completion Date

March 13, 2020

Conditions
Infant Gut Microbiome
Interventions
OTHER

B. infantis EVC001

"Bifidobacterium longum subspecies infantis strain EVC001, designated a Foods for Special Dietary Use (FSDU)"

OTHER

Lacto-N-tetraose (LNT)

LNT is a human milk oligosaccharide (HMO) found in human breast milk and is a selective prebiotic for B. infantis.

Trial Locations (1)

29414

Coastal Pediatric Research, Charleston

Sponsors
All Listed Sponsors
lead

Evolve BioSystems, Inc.

INDUSTRY

NCT03994315 - The EFFECT Study: Probiotic and HMO Supplementation in Infants | Biotech Hunter | Biotech Hunter